\-\ Texto\\:\\ \ \(0\)\
\-\ blood\\ pressure\\ measured\\ 162\\/96\\.\\ \\ remaining\\ vital\\ signs\\ were\\ normal\\.\\ \\ labs\\ to\\ include\\ cbc\\,\\ comprehensive\\ metabolic\\ panel\\,\\ tsh\\,\\ aldosterone\\,\\ vma\\ and\\ metanephrines\\ were\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ percutaneous\\ transluminal\\ angioplasty\\.\\ \\ in\\ patient\\'s\\ who\\ undergo\\ pta\\,\\ periodic\\ blood\\ pressure\\ measurements\\ should\\ be\\ followed\\.\ \(0\)\
\-\ string\\ of\\ beads\\ appearance\\ with\\ alternating\\ segments\\ of\\ stricture\\ and\\ dilation\\ of\\ the\\ mid\\ to\\ distal\\ right\\ renal\\ artery\\.\\ \\ the\\ patient\\ was\\ found\\ to\\ have\\ two\\ left\\ renal\\ arteries\\,\\ with\\ the\\ more\\ inferior\\ artery\\ demonstrating\\ the\\ string\\ of\\ beads\\ appearance\\.\ \(0\)\
\-\ fibromuscular\\ dysplasia\ \(11\)\
\-\ 1\\.\\ \\ fibromuscular\\ dysplasia\\.\ \(0\)\
\-\ 2\\.\\ \\ atherosclerotic\\ renal\\ artery\\ disease\\,\\ however\\ this\\ is\\ most\\ likely\\ to\\ be\\ seen\\ at\\ the\\ origin\\ of\\ the\\ renal\\ artery\\ in\\ an\\ older\\ patient\\ with\\ cardiovascular\\ risk\\ factors\\.\ \(0\)\
\-\ 3\\.\\ \\ polyarteritis\\ nodosa\\,\\ however\\ the\\ aneurysms\\ tend\\ to\\ be\\ smaller\\ and\\ more\\ peripheral\\.\ \(0\)\
\-\ 4\\.\\ \\ other\\ vasculitides\\.\ \(0\)\
\-\ 47\\ year\\ old\\ female\\ with\\ hypertension\\,\\ uncontrolled\\ with\\ multiple\\ antihypertensive\\ medications\\.\\ \\ patient\\ is\\ a\\ nonsmoker\\ and\\ generally\\ feels\\ well\\.\ \(0\)\
\-\ this\\ patient\\ underwent\\ pta\\ and\\ had\\ a\\ significant\\ decrease\\ in\\ blood\\ pressure\\,\\ allowing\\ good\\ control\\ with\\ a\\ single\\ antihypertensive\\ medication\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ antihypertensive\\:\\ 0\\.23784741070711973\ \(0\)\
\-\ beads\\:\\ 0\\.22582847506638315\ \(0\)\
\-\ pta\\:\\ 0\\.21730090451925416\ \(0\)\
\-\ renal\\:\\ 0\\.21059512335725916\ \(0\)\
\-\ artery\\:\\ 0\\.21003317900611024\ \(0\)\
\-\ string\\:\\ 0\\.19675439833138855\ \(0\)\
\-\ fibromuscular\\:\\ 0\\.19326303323778105\ \(0\)\
\-\ pressure\\:\\ 0\\.1931226550465645\ \(0\)\
\-\ blood\\:\\ 0\\.14730214263801997\ \(0\)\
\-\ patient\\:\\ 0\\.13749179655563903\ \(0\)\
\-\ dysplasia\\:\\ 0\\.12950530358306866\ \(0\)\
\-\ aldosterone\\:\\ 0\\.12493317317392813\ \(0\)\
\-\ transluminal\\:\\ 0\\.12493317317392813\ \(0\)\
\-\ metanephrines\\:\\ 0\\.12162592437710266\ \(0\)\
\-\ nonsmoker\\:\\ 0\\.11892370535355987\ \(0\)\
\-\ the\\:\\ 0\\.11808903086128454\ \(0\)\
\-\ vma\\:\\ 0\\.116639011722998\ \(0\)\
\-\ vasculitides\\:\\ 0\\.116639011722998\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.11291423753319157\ \(0\)\
\-\ nodosa\\:\\ 0\\.10865045225962708\ \(0\)\
\-\ to\\:\\ 0\\.1056808618598254\ \(0\)\
\-\ uncontrolled\\:\\ 0\\.10438666698606257\ \(0\)\
\-\ be\\:\\ 0\\.10289001026528438\ \(0\)\
\-\ comprehensive\\:\\ 0\\.10264098443925879\ \(0\)\
\-\ alternating\\:\\ 0\\.10264098443925879\ \(0\)\
\-\ appearance\\:\\ 0\\.10193823396407121\ \(0\)\
\-\ feels\\:\\ 0\\.10035629080869693\ \(0\)\
\-\ however\\:\\ 0\\.10008192899969852\ \(0\)\
\-\ with\\:\\ 0\\.09933022345719683\ \(0\)\
\-\ measurements\\:\\ 0\\.09837719916569428\ \(0\)\
\-\ allowing\\:\\ 0\\.09609250553513242\ \(0\)\
\-\ angioplasty\\:\\ 0\\.0955724110733327\ \(0\)\
\-\ periodic\\:\\ 0\\.0950699503688688\ \(0\)\
\-\ more\\:\\ 0\\.09284888395112295\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.09044019165444517\ \(0\)\
\-\ aneurysms\\:\\ 0\\.09044019165444517\ \(0\)\
\-\ panel\\:\\ 0\\.08873472940720156\ \(0\)\
\-\ and\\:\\ 0\\.08735131136608827\ \(0\)\
\-\ were\\:\\ 0\\.08716137384233254\ \(0\)\
\-\ tend\\:\\ 0\\.08635826352495772\ \(0\)\
\-\ segments\\:\\ 0\\.08581925244119962\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.0852991579793999\ \(0\)\
\-\ measured\\:\\ 0\\.08338408877414533\ \(0\)\
\-\ of\\:\\ 0\\.08272575759388082\ \(0\)\
\-\ stricture\\:\\ 0\\.08189004506137841\ \(0\)\
\-\ tsh\\:\\ 0\\.08168839336171474\ \(0\)\
\-\ percutaneous\\:\\ 0\\.08148944847811052\ \(0\)\
\-\ remaining\\:\\ 0\\.08034879570458944\ \(0\)\
\-\ undergo\\:\\ 0\\.07895283085663417\ \(0\)\
\-\ older\\:\\ 0\\.07846147631326877\ \(0\)\
\-\ medication\\:\\ 0\\.07814272916183905\ \(0\)\
\-\ 47\\:\\ 0\\.07752509099026947\ \(0\)\
\-\ metabolic\\:\\ 0\\.07664436629669058\ \(0\)\
\-\ smaller\\:\\ 0\\.07608501043102493\ \(0\)\
\-\ vital\\:\\ 0\\.07528367088327333\ \(0\)\
\-\ dilation\\:\\ 0\\.07440044620296465\ \(0\)\
\-\ origin\\:\\ 0\\.07277776163419945\ \(0\)\
\-\ decrease\\:\\ 0\\.07266837979978498\ \(0\)\
\-\ control\\:\\ 0\\.07223875055044135\ \(0\)\
\-\ generally\\:\\ 0\\.07161679196744562\ \(0\)\
\-\ factors\\:\\ 0\\.07151562316990119\ \(0\)\
\-\ medications\\:\\ 0\\.07092269725298121\ \(0\)\
\-\ cbc\\:\\ 0\\.07054019418417648\ \(0\)\
\-\ demonstrating\\:\\ 0\\.0697140327058326\ \(0\)\
\-\ normal\\:\\ 0\\.06903860209535816\ \(0\)\
\-\ good\\:\\ 0\\.06876307754013389\ \(0\)\
\-\ arteries\\:\\ 0\\.06710136785984426\ \(0\)\
\-\ limits\\:\\ 0\\.06680493455262222\ \(0\)\
\-\ single\\:\\ 0\\.06501041778934052\ \(0\)\
\-\ hypertension\\:\\ 0\\.06468890471996075\ \(0\)\
\-\ in\\:\\ 0\\.06309642052597436\ \(0\)\
\-\ mid\\:\\ 0\\.06084446238445179\ \(0\)\
\-\ peripheral\\:\\ 0\\.06045695870953748\ \(0\)\
\-\ risk\\:\\ 0\\.0604092254274013\ \(0\)\
\-\ signs\\:\\ 0\\.059087877909026705\ \(0\)\
\-\ labs\\:\\ 0\\.058573797312715226\ \(0\)\
\-\ underwent\\:\\ 0\\.05824072326670214\ \(0\)\
\-\ this\\:\\ 0\\.05810261219038843\ \(0\)\
\-\ inferior\\:\\ 0\\.05751759588616199\ \(0\)\
\-\ followed\\:\\ 0\\.057092448394122655\ \(0\)\
\-\ should\\:\\ 0\\.05516583801767875\ \(0\)\
\-\ found\\:\\ 0\\.05470469771354747\ \(0\)\
\-\ likely\\:\\ 0\\.05052221363832115\ \(0\)\
\-\ include\\:\\ 0\\.050303715755453025\ \(0\)\
\-\ two\\:\\ 0\\.050207630029665475\ \(0\)\
\-\ distal\\:\\ 0\\.049122951533112594\ \(0\)\
\-\ significant\\:\\ 0\\.04881462481509392\ \(0\)\
\-\ who\\:\\ 0\\.047824071405147175\ \(0\)\
\-\ is\\:\\ 0\\.04630663906758092\ \(0\)\
\-\ most\\:\\ 0\\.04399996226057965\ \(0\)\
\-\ other\\:\\ 0\\.04390575958353707\ \(0\)\
\-\ have\\:\\ 0\\.042235041657594764\ \(0\)\
\-\ had\\:\\ 0\\.04212360375446751\ \(0\)\
\-\ multiple\\:\\ 0\\.04135297257911838\ \(0\)\
\-\ well\\:\\ 0\\.040937277073329406\ \(0\)\
\-\ female\\:\\ 0\\.04079703268564725\ \(0\)\
\-\ seen\\:\\ 0\\.03980326801143641\ \(0\)\
\-\ within\\:\\ 0\\.03893898287360164\ \(0\)\
\-\ disease\\:\\ 0\\.03548913601906751\ \(0\)\
\-\ an\\:\\ 0\\.03232985948849173\ \(0\)\
\-\ at\\:\\ 0\\.03193385043796723\ \(0\)\
\-\ was\\:\\ 0\\.02946489282982286\ \(0\)\
\-\ left\\:\\ 0\\.02884026410811181\ \(0\)\
\-\ right\\:\\ 0\\.02803028291211377\ \(0\)\
\-\ year\\:\\ 0\\.02605521347854169\ \(0\)\
\-\ old\\:\\ 0\\.02502202417537217\ \(0\)\
